文献速递皮肤肿瘤

原发性皮肤黑色素瘤中IDO表达与Breslow厚度相关且对无进展生存具显著预后价值

Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival.
PubMed 文献 · J Invest Dermatol · 2017-10-18

本研究分析原发性人黑色素瘤中吲哚胺2,3-双加氧酶(IDO)的表达,发现黑色素瘤细胞IDO表达与Breslow厚度、肿瘤浸润淋巴细胞及瘤周炎症浸润强度显著相关,且独立于Breslow厚度和肿瘤分期预测无进展生存;抗原呈递细胞IDO强阳性与无进展生存负相关。

要点

  • 黑色素瘤细胞IDO表达与Breslow厚度显著相关(P=0.003)。
  • 黑色素瘤细胞IDO表达独立于Breslow厚度和肿瘤分期预测无进展生存(P=0.04)。
  • 抗原呈递细胞IDO强阳性与无进展生存显著负相关。

核心结论

  • 黑色素瘤细胞IDO诱导可能直接反映肿瘤进展。
  • 抗原呈递细胞IDO可能决定免疫监视并影响局部和全身免疫耐受。

研究设计与样本

  • 研究分析原发性人黑色素瘤中IDO表达,样本量未报告。

主要发现

  • 黑色素瘤细胞IDO表达水平与Breslow厚度显著相关(P=0.003)。
  • 黑色素瘤细胞IDO表达与肿瘤浸润淋巴细胞存在显著相关(P=0.029)。
  • 黑色素瘤细胞IDO表达与瘤周炎症浸润强度显著相关(P=0.001)。
  • 黑色素瘤细胞IDO表达独立于Breslow厚度和肿瘤分期预测无进展生存(P=0.04)。
  • 肿瘤微环境中CD11c+树突状细胞和CD68+巨噬细胞表达IDO。

临床怎么用

  • 黑色素瘤细胞IDO表达可作为反映肿瘤进展的潜在标志物。
  • 抗原呈递细胞IDO强阳性提示免疫监视受损,可能影响预后评估。

局限性

  • 原文指出原发性人黑色素瘤IDO表达数据不完整且存在矛盾。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The enzyme indoleamine 2,3-dioxygenase (IDO) is emerging as a facilitator of cancer development through its effects on cancer-associated inflammation. Recent studies report a significant improvement of the response rates in melanoma patients to PD-1 antibodies when IDO inhibitors were added to the regimen. Data on IDO expression in primary human melanomas are, however, incomplete and conflicting. Here, we show that the level of IDO expression in primary human melanoma cells significantly correlates with Breslow thickness (P = 0.003), the presence of tumor-infiltrating lymphocytes (P = 0.029), and the intensity of the peritumoral inflammatory infiltrate (P = 0.001). The expression of IDO in melanoma cells predicted independently of Breslow thickness and tumor stage (P = 0.04). We further show that CD11c+ dendritic cells and CD68+ macrophages in the microenvironment of melanomas express IDO. The level of IDO expression in antigen-presenting cells correlated positively to peritumoral inflammation (P = 0.001) but not to tumor-infiltrating lymphocytes. Significant negative correlation with progression-free survival was found for patients for whom antigen-presenting cells were very strongly IDO positive. These results suggest that IDO induction within melanoma cells may directly reflect tumor progression, whereas IDO in antigen-presenting cells may determine immune surveillance with impact on local and systemic tolerance.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Rubel F, Kern JS, Technau-Hafsi K, et al. Indoleamine 2,3-Dioxygenase Expression in Primary Cutaneous Melanoma Correlates with Breslow Thickness and Is of Significant Prognostic Value for Progression-Free Survival. J Invest Dermatol. 2017. PMID: 29054599. doi:10.1016/j.jid.2017.09.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。